Using AI to improve the detection of trachoma in children
The Development of Clinically-Motivated and Explainable Machine-Learning-Based Image Classifiers to Detect Trachoma
This study is working on using smart computer technology to help find trachoma, a disease that can cause vision loss in kids under 12, so that even in places with fewer doctors, we can still make sure children get the right diagnosis and care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project ID | NIH-11050191 on NIH RePORTER |
What this research studies
This research focuses on developing advanced machine learning algorithms to analyze images for detecting trachoma, a leading cause of vision loss in children under 12. By utilizing AI technology, the project aims to create a reliable and standardized method for diagnosing active trachoma, which is crucial for monitoring and eliminating the disease. The approach involves training AI models on previously collected photographs to enhance diagnostic accuracy and reduce reliance on human graders. This innovative method seeks to ensure that even in areas with fewer trained professionals, accurate assessments can still be made.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under the age of 12 living in regions where trachoma is prevalent.
Not a fit: Patients who do not live in areas affected by trachoma or who are over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and accessible diagnosis of trachoma, ultimately reducing the risk of vision loss in affected children.
How similar studies have performed: Previous research has shown promise in using AI for medical image analysis, indicating that this approach could be effective for trachoma detection as well.
Where this research is happening
Burlington, United States
- University of Vermont & St Agric College — Burlington, United States (Active)
Researchers
- Principal investigator: Brady, Christopher John — University of Vermont & St Agric College
- Study coordinator: Brady, Christopher John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.